Mariner LLC Boosts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Mariner LLC raised its position in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 13.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,553 shares of the company’s stock after buying an additional 993 shares during the quarter. Mariner LLC’s holdings in Addus HomeCare were worth $1,072,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ADUS. American Century Companies Inc. lifted its position in Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock valued at $35,643,000 after purchasing an additional 248,613 shares during the last quarter. TimesSquare Capital Management LLC grew its position in Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock worth $44,593,000 after acquiring an additional 78,835 shares in the last quarter. Principal Financial Group Inc. increased its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Pier Capital LLC purchased a new stake in Addus HomeCare during the fourth quarter valued at approximately $8,406,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Addus HomeCare in the 4th quarter valued at approximately $6,637,000. 95.35% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on ADUS. StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Macquarie reissued an “outperform” rating and issued a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. Oppenheimer raised their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Stephens reiterated an “overweight” rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, JMP Securities restated a “market outperform” rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Tuesday, April 22nd. One analyst has rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Buy” and an average price target of $139.00.

Addus HomeCare Stock Up 1.0 %

Shares of NASDAQ:ADUS opened at $100.58 on Friday. The business’s 50 day moving average is $97.93 and its 200 day moving average is $116.06. The stock has a market cap of $1.83 billion, a P/E ratio of 23.02, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 EPS for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. On average, sell-side analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.